RecallDepth
Class II Terminated

Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in (a) 150 mL bottle (NDC 0093-4150-80) (b) 80 mL bottle (NDC 0093-4150-79), Rx Only, Manufactured in Canada By: Teva Canada Limited Toronto, Canada, M1B2K9, Manufactured For: Teva Pharmaceuticals USA, INC. North Wales, PA 19454.

Company
Teva Pharmaceuticals Usa
Recall Initiated
April 12, 2019
Posted
April 24, 2019
Recall Number
D-1205-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
171,488 150 mL and 80 mL bottles
Firm Location
North Wales, PA, United States

Reason for Recall

Subpotent Product: assay results for Amoxicillin were below the specification limits.

Distribution

Nationwide in the USA and Puerto Rico

Lot / Code Info

Lots: (a) Lot # 35436769A, exp. date 05/2019; 35438389A, 35438390A, exp. date 01/2020; 35440838A, exp. date 10/2020; (b) 35437491A, 35443574B, exp. date 09/2021

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls